Investment Rating - The report assigns a "Buy" rating for BYD Co. with a 12-month price target of Rmb424 for A shares and HK$416 for H shares, indicating an upside potential of 11.3% for A shares and a downside of 2.2% for H shares [11][12]. Core Insights - The impact of BYD's "618" promotions on its sales may be less severe than initially feared, as the price reductions include existing government and OEM trade-in subsidies [2][3]. - The promotion affects 12 models with an average price reduction of Rmb10k, translating to a 9% discount, which could lead to an estimated Rmb2.6 billion impact on BYD's top line, equating to 5% of the projected net profit for 2025 [3][4]. - If competitors follow suit with similar pricing strategies, the potential impact on BYD could escalate to Rmb12.4 billion [4]. Summary by Sections Promotion Impact - BYD's "618" promotions involve discounts on 22 models, primarily priced below Rmb200k, with limited-time pricing until the end of June [1]. - The average blended ASP of the 12 models affected is Rmb114k, and these models accounted for significant portions of BYD's volume, revenue, and gross profit in Q1 2025 [3]. Financial Estimates - Following the promotion announcement, net profit estimates for 2025E-2027E have been reduced by 3%-5%, and target prices have been adjusted downwards by 3% [6]. - The report provides updated revenue forecasts, projecting Rmb777.1 billion for 2025, with a gradual increase to Rmb1.18 trillion by 2027 [11]. Competitive Landscape - The report highlights that traditional OEMs dominate the NEV sales volume mix in the below Rmb200k segment, indicating a competitive pricing environment [5][10]. - BYD's market position is reinforced by its strong competitive moat due to its vertical integration business model, positioning it as a leading global auto OEM [8].

Investment Rating - The investment rating for Alibaba Health (0241.HK) is Neutral with a 12-month target price of HK$4.10 per share, indicating a downside potential of 8.9% from the current price of HK$4.50 [2][9]. Core Insights - Alibaba Health's management expressed confidence in achieving or exceeding the FY26 guidance, which includes a 5%-10% year-over-year growth in topline revenue and a 10%-20% year-over-year growth in adjusted net profit [3][6]. - The potential for asset injection from the parent company is being considered, with a focus on business synergy and operational outcomes [7]. - The management is evaluating the expansion of its O2O (Online to Offline) business, contingent on the pace of investment from the parent company in on-demand delivery initiatives [8]. Summary by Sections Guidance and Latest Updates - Management is confident in delivering or exceeding the high-end of the FY26 guidance, which targets a 5%-10% year-over-year growth in topline revenue and a 10%-20% year-over-year growth in adjusted net profit [3][6]. Asset Injection Potential - The primary consideration for potential asset injection from the parent group is the existence of business synergy and improved operational outcomes. Two potential directions include the drugs and nutrition products business from Tmall International and the O2O business from Ele.me [7]. O2O Business Insights - Alibaba Health is monitoring the decision to enhance its O2O business based on the parent company's investment pace in on-demand delivery. Key factors for O2O business success include offline pharmacies, preposition warehouses, a rider fleet, and user mindshare, which is expected to be bolstered by Taobao's Shan Gou initiative [8].

Investment Rating - The report assigns a "Buy" rating for Meituan (3690.HK) with a target price of HK$172.00, representing an upside of 32.9% from the current price of HK$129.40 [1]. Core Insights - The report highlights a solid profit beat for Meituan in 1Q25, driven by strong local commerce profits, although it anticipates mixed reactions due to increased competition in the food delivery sector leading to higher subsidies [1][7]. - Meituan is aggressively defending its leadership in food delivery, expecting a healthy growth in food delivery volume into 2Q25, with a forecast of 9% year-over-year growth [7][20]. - The competitive landscape is becoming more fragmented, with expectations of a three-player market, which may impact future profitability [22]. Financial Forecasts - Revenue forecasts for Meituan have been adjusted, with 2025 estimates showing a revenue of Rmb382,513.3 million, reflecting a growth of 11% year-over-year [3][20]. - The adjusted EBIT for the core local commerce segment is projected at Rmb44.7 billion for 2025, down from previous estimates due to increased competition and subsidies [20][22]. - The report anticipates a decline in food delivery EBIT by 33% for 2025 due to increased user subsidies [20]. Market Position and Strategy - Meituan maintains a leading position with over 14.5 million local service merchants and a strong user base, supported by membership programs [7][15]. - The company is focusing on expanding its Instashopping segment, which is expected to grow by 27% in 2Q25, driven by improved purchase frequency among users [17][20]. - Meituan's strategy includes significant investments in AI to enhance operational efficiency and drive growth, with a projected capex of Rmb14 billion for FY25 [20][22]. Valuation Metrics - The report provides various valuation metrics, including a P/E ratio of 15.9 for 2024 and a projected P/B ratio of 4.0 [3][9]. - The estimated free cash flow yield for 2024 is 6.6%, indicating a strong cash generation capability [9][10]. - The report reflects a downward adjustment in the target price from HK$200 to HK$172, considering the competitive pressures and revised profit expectations [22][28].

Deploying advanced nuclear reactor technologies for national security. Under this executive order, the administration is to ensure the rapid development, Goldman Sachs does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. For Reg AC certification and oth ...

26 May 2025 | 7:59PM EDT Oil Comment: GS Top Projects Takeaways: Strong Supply in 2025-2026, Tighter Later n We identify takeaways from our equity analysts' 2025 Top Projects review of the world's major upstream oil projects. This review supports our below-the-forwards Brent/WTI oil price forecasts of $60/56 for the remainder of 2025 and $56/52 in 2026, but has positive implications for prices in the long term. n 2025-2026: Strong Non-OPEC ex Shale Supply, Lower Prices n Long Term: Tighter Supply, Higher Pr ...

26 May 2025 | 6:39PM EDT US Daily: Why We Only Expect a One-Time Inflation Boost from Tariffs (Mericle) Jan Hatzius +1(212)902-0394 | jan.hatzius@gs.com Goldman Sachs & Co. LLC Alec Phillips +1(202)637-3746 | alec.phillips@gs.com Goldman Sachs & Co. LLC David Mericle +1(212)357-2619 | david.mericle@gs.com Goldman Sachs & Co. LLC Ronnie Walker +1(917)343-4543 | ronnie.walker@gs.com Goldman Sachs & Co. LLC Manuel Abecasis +1(212)902-8357 | manuel.abecasis@gs.com Goldman Sachs & Co. LLC Elsie Peng +1(212)357-3 ...

Investment Rating - The report maintains a "Buy" rating for Miniso, with a 12-month price target of $23.40 for ADR and HK$46.00 for H-share, indicating an upside potential of 27.9% and 33.1% respectively [14][17]. Core Insights - Management is confident in achieving revenue growth acceleration in 2025, targeting a year-over-year increase of 23% compared to 2024, with a focus on low teens percentage growth in Miniso China and around 40% growth in overseas markets [1][8]. - Despite expected margin pressure in the short term, management anticipates a return to positive operating profit growth by the third quarter of 2025, with a narrowing of margin contraction [1][2]. - The company plans to close 300-400 underperforming stores in China, with expectations of a return to net store count growth in the second half of 2025 [1][12]. Summary by Sections Financial Performance - For 2025, Miniso aims for revenue of Rmb20,554 million, with an operating profit (OP) target of Rmb3.6 billion to Rmb3.8 billion, compared to Rmb3.2 billion in the previous year [17]. - In 2Q25, management expects topline growth of 18%-21%, with specific growth rates of low teens for Miniso China and 25%-30% for overseas markets [8]. Market Strategy - The company is focusing on optimizing its product offerings in the US, with IP-related products making up 60-70% of sales, and plans to increase local sourcing to mitigate tariff impacts [12][15]. - Miniso's store expansion strategy includes targeting 80-100 net new store openings in 2025, with a significant portion being DTC stores [10][11]. Operational Efficiency - Management noted that logistics costs have declined, and there is potential for cost savings through improved store productivity and geographical concentration of store openings [10][12]. - The average payback period for new stores is reported to be 15-18 months, with daily sales averaging nearly Rmb10,000, significantly above the breakeven point [13].

Investment Rating - The investment rating for Huafeng is not explicitly stated in the provided documents, but there is a positive outlook on the company's performance and growth potential in the AI server market [2][4][8]. Core Insights - Huafeng's management is optimistic about the demand growth for high-speed line modules and backplane connectors for AI servers, expecting to ramp up production capacities in the second quarter of 2025 [1][4]. - The company is expanding its customer base to include more Chinese server brands and cloud service providers, indicating a strategic move to diversify its market presence [1][8]. - The positive outlook on Huafeng aligns with the broader positive sentiment regarding the China AI supply chain and advanced semiconductor nodes, suggesting a favorable environment for growth [2][4]. Summary by Sections Company Profile - Huafeng Tech (688629.SS) specializes in connectors and interconnection solutions for servers, industrial applications, and automotive sectors, with a focus on high-speed backplane connectors and line modules ranging from 10GB/s to 112GB/s [3][4]. Demand and Production Capacity - The demand for high-speed line modules is driven by the AI server market, with Huafeng's products currently in mass production for 56G and 112G applications, and development ongoing for 200G/224G products [4][9]. - The company has invested in six production lines for high-speed modules, with expectations for production to stabilize in the second half of the year as capacity ramps up [9]. Strategic Partnerships - Management sees potential for partnerships with Chinese server brands and cloud service suppliers, aiming to generate revenue from a more diversified customer base this year [8][9].

Investment Rating - The report assigns a "Buy" rating to GigaDevice, indicating a positive outlook for the company's stock performance [1][10][14]. Core Insights - GigaDevice is expected to enter a new growth cycle driven by product expansion into specialty DRAM, with strong EPS growth anticipated from market share gains in China [10]. - The NOR flash and MCU segments are projected to remain stable, with a modest recovery expected into 2025-2026 [10]. - The pricing for specialty DRAM has started to recover, driven by customer restocking and supply reductions as incumbents exit the legacy DRAM segment [4][10]. NOR Flash - Pricing for NOR flash is expected to be stable in 2025, with healthy near-term demand supported by consumption subsidies and increased content opportunities driven by AI [2]. - The automotive NOR flash market is projected to grow significantly, with a year-on-year increase of 40%-50%, although sales remain at a relatively low base [2]. MCU - MCU pricing is anticipated to remain largely stable in 2025, with growth driven by industrial customers' restocking demand and new market expansions [3]. - The automotive MCU sales are expected to take an additional year or two to reach meaningful scale due to the time required for product testing and qualifications [3]. Specialty DRAM - Specialty DRAM pricing has bottomed out and started recovering since March, with double-digit percentage increases observed in DDR4 8Gb and 4Gb products [4][7]. - Demand for specialty DRAM is expected to be bolstered by China's consumption subsidies on electronic products and new product expansions [7]. Customized DRAM - GigaDevice's customized DRAM leverages existing DDR4 production processes tailored to customer requirements, focusing on specialty applications such as automotive and industrial sectors [8]. - Revenue contribution from customized DRAM is expected to be limited in 2025 but could become more significant in the second half of 2026 to early 2027 [8]. Financial Projections - The revenue forecast for GigaDevice shows a growth trajectory from Rmb7,356 million in 2025 to Rmb14,200 million by 2027, indicating a compound annual growth rate [9]. - The expected EPS is projected to increase from Rmb1.65 in 2025 to Rmb5.17 by 2027, reflecting strong earnings growth [14].

27 May 2025 | 8:39AM HKT TechNet China 2025: AD/ ADAS solution solid delivery growth; balancing costs and advanced features We hosted iMotion's management on May 21 at our TechNet Conference China 2025. Overall, key discussions were around the company's product pipeline and business focus, as well as their strategy on chipset supplier partnership. Overall, iMotion obtained solid growth in its front view all-in-one systems and domain controllers, and is positive on their progress of customer development. Apa ...